Home Newsfeeds Morgan Stanley Maintains Overweight on Nasdaq, Raises Price Target to $68

Morgan Stanley Maintains Overweight on Nasdaq, Raises Price Target to $68

Morgan Stanley analyst Michael Cyprys maintains Nasdaq (NASDAQ:NDAQ) with a Overweight and raises the price target from $67 to $68.

byBenzinga Newsdesk

August 30, 2022

1 minute read

Morgan Stanley analyst Michael Cyprys maintains Nasdaq (NASDAQ:NDAQ) with a Overweight and raises the price target from $67 to $68.

News

Sesame Partners With Lucira Health As Official Telehealth Provider Of Lab-Quality Test-To-Treat Program

By Benzinga Newsdesk

January 5, 10:22 AM

New partnership enables a free Sesame telehealth consultation with purchase of a Lucira at-home COVID-19 test, providing a full test-to-treat experience from the comfort of home, within two hours NEW

LHDX

Coinbase Legal Setback: Court Rejects Motion To Dismiss SEC’s Securities Allegations

By Murtuza Merchant

March 27, 11:03 AM

Major setback for Coinbase as court rules against its motion to dismiss SEC lawsuit. Allegations of unregistered securities activity and staking program deemed unregistered security offering.

COIN

Morgan Stanley Maintains Equal-Weight on Exscientia, Lowers Price Target to $18

By Benzinga Newsdesk

August 24, 7:58 AM

Morgan Stanley analyst Vikram Purohit maintains Exscientia (NASDAQ:EXAI) with a Equal-Weight and lowers the price target from $20 to $18.

EXAI

Bird Announces Purchases Of Shares By Management And Directors Totaling Over 1.5M Shares Purchased

By Happy Mohamed

March 27, 8:19 AM

Bird Global, Inc. (NYSE:BRDS, ", Bird", )))), a leader in environmentally friendly electric transportation, today announced completed purchases of BRDS Class A common stock on the open market by certain officers

BRDS

Morgan Stanley Maintains Overweight on Nasdaq, Raises Price Target to $68

Related Posts

Sesame Partners With Lucira Health As Official Telehealth Provider Of Lab-Quality Test-To-Treat Program

Coinbase Legal Setback: Court Rejects Motion To Dismiss SEC’s Securities Allegations

Morgan Stanley Maintains Equal-Weight on Exscientia, Lowers Price Target to $18

Bird Announces Purchases Of Shares By Management And Directors Totaling Over 1.5M Shares Purchased